Brainstorm Cell Therapeutics Inc.
BCLI
$0.642
-$0.0032-0.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.88% | 779.14% | 11.31% | -95.16% | 345.31% |
| Total Receivables | 58.21% | 6.35% | 57.50% | 21.21% | 26.92% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.80% | 360.00% | -13.46% | -50.32% | -30.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.03% | 505.71% | 5.77% | -90.46% | 203.10% |
|
|
|||||
| Total Current Assets | -35.03% | 505.71% | 5.77% | -90.46% | 203.10% |
| Net Property, Plant & Equipment | -20.19% | -16.60% | -14.88% | -12.59% | -11.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.29% | -0.97% | 1.48% | 2.01% | -1.49% |
| Total Assets | -28.14% | 94.92% | -9.53% | -64.37% | 69.74% |
|
|
|||||
| Total Accounts Payable | -11.77% | 11.79% | 32.09% | -13.80% | 13.86% |
| Total Accrued Expenses | -31.78% | -13.09% | -28.44% | 20.47% | 12.89% |
| Short-term Debt | -91.58% | 300.00% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.00% | -19.31% | -3.68% | 0.71% | -3.74% |
| Total Finance Division Other Current Liabilities | -12.53% | 34.48% | 36.97% | -2.16% | 16.36% |
| Total Other Current Liabilities | -12.53% | 34.48% | 36.97% | -2.16% | 16.36% |
| Total Current Liabilities | -21.77% | 21.42% | 26.77% | -7.92% | 12.59% |
|
|
|||||
| Total Current Liabilities | -21.77% | 21.42% | 26.77% | -7.92% | 12.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -91.58% | 300.00% | -- | -- | -- |
| Capital Leases | -25.20% | -25.73% | -36.90% | -31.57% | -25.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -38.68% | -35.08% | -26.79% |
| Total Liabilities | -21.81% | 14.92% | 18.73% | -12.25% | 3.51% |
|
|
|||||
| Common Stock & APIC | 1.94% | 1.45% | 0.58% | 0.08% | 2.14% |
| Retained Earnings | -1.26% | -1.26% | -1.33% | -1.23% | -1.16% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 18.77% | 3.95% | -28.18% | -71.73% | 36.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.77% | 3.95% | -28.18% | -71.73% | 36.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.77% | 3.95% | -28.18% | -71.73% | 36.45% |
|
|
|||||